biologics

Apogee Therapeutics to present 52-week Phase 2 data for APG777 in atopic dermatitis on March 23, 2026, signaling major clinical development milestone.

Global pharmaceutical packaging market projected to grow 41% from $154.78B in 2025 to $219.08B by 2031, driven by injectable drug demand and sustainability requirements.

Global cytokines market projected to grow from $95.32B (2025) to $174.53B (2032) at 9.02% CAGR, driven by manufacturing advances and strategic partnerships.

U.S. clinical trial packaging market expected to nearly triple to $2.7 billion by 2035, driven by increased R&D spending and demand for advanced, specialized packaging solutions.

Totaligent secures joint venture with Japanese medical distributor GloMed Solutions, with option to acquire full ownership within one year, expanding into high-growth aesthetics market.

Global ophthalmic drug market projected to reach $41.88B by 2026, growing 7.9% annually driven by biologic therapies, advanced delivery systems, and AI-enabled diagnostics.

Pharmaceutical glass packaging market expected to nearly double from $5.32B in 2025 to $12.39B by 2035, driven by injectable drugs, biologics, and stricter EU regulations.

Biopharmaceutical CMO market to grow from $21.16B in 2025 to $76.2B by 2035, driven by outsourcing demand and capacity constraints.